| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/24/2008 | CN100444829C Freeze-dry snow lotus powder for venous injection and its preparation method |
| 12/24/2008 | CN100444828C Preparation method of biodegradable polymer pharmaceutical microsphere |
| 12/24/2008 | CN100444814C Prosthetic foot with tunable performance |
| 12/24/2008 | CN100444734C A compound antivirus sprayer and preparation method thereof |
| 12/24/2008 | CA2691654A1 Treatment of meconium aspiration syndrome with estrogens |
| 12/24/2008 | CA2691393A1 Derma membrane structure (dms) in foam creams |
| 12/24/2008 | CA2690945A1 Composition for transdermal or transmucosal administration |
| 12/24/2008 | CA2690934A1 Liposome composition |
| 12/24/2008 | CA2690119A1 Use of taci-ig fusion protein such as atacicep for the manufacture of a medicament for treating lupus erythematosus |
| 12/24/2008 | CA2689467A1 Pharmaceutical solid preparation comprising benzazepines and production method thereof |
| 12/24/2008 | CA2687968A1 Stabilized thrombin compositions |
| 12/24/2008 | CA2679154A1 Cationic latex as a carrier for bioactive ingredients and methods for making and using the same |
| 12/23/2008 | US7468470 Medicinal patch that leaves less adhesive residue when removed |
| 12/23/2008 | US7468444 Crystalline polymorphic dosage forms of anticholesterol agents; statins; suspending atorvastatin hemi-calcium in water for 16 hours convert the atorvastatin hemi-calcium into Form I |
| 12/23/2008 | US7468394 Mixing propofol, oil and egg lecithin, adding mixture of water and glycerin; entrapping propofol within shells of liposome particles; emulsification by use of a homogenizer, adjusting final volume and pH,filling, closing and sealing, sterilization, candling, packaging |
| 12/23/2008 | US7468391 Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B |
| 12/23/2008 | US7468195 Skin treatment preparation |
| 12/23/2008 | US7468194 Administering liposomes containing povidone iodine for therapy of bacterial infection |
| 12/23/2008 | US7468191 Stability; gas delivery agent used in cosmetic or therapeutic product; mixing fluorocarbon immiscible hydrophilic liquid and a solid emulsifying agent by agitation, adding fluorocarbon, dispersion, gasification |
| 12/23/2008 | US7468179 Aerosol for delivery of naltrexone, buprenorphine, nalbuphine, naloxone, butorphanol, hydromorphone, oxycodone, methadone, remifentanil, sufentanil, or fentanyl by vaporizing the drug, which is coated on support and condensing to form aerosol with mass median aerodynamic diameter of less than 5 microns |
| 12/23/2008 | US7468172 Hydroxapatite calcium phosphates, their methods of preparation and their applications |
| 12/23/2008 | US7468151 Method for the preparation of purified microparticles |
| 12/23/2008 | CA2602643C Composition for improving blood cholesterol levels |
| 12/23/2008 | CA2596320C Nucleotide analog compositions |
| 12/23/2008 | CA2490414C Device and method for delivering an oral care agent |
| 12/23/2008 | CA2426074C Inhalable formulation of a solution containing a tiotropium salt |
| 12/23/2008 | CA2419993C Process for preparing pharmaceutical compositions for use with soft gelatin formulations |
| 12/23/2008 | CA2419067C Injectable composition comprising benzimidazole compound and strong alkali |
| 12/23/2008 | CA2387370C Percutaneous sorbefacients for electroporation |
| 12/23/2008 | CA2379003C Therapy of respiratory influenza virus infection using free and liposome-encapsulated ribonucleotides |
| 12/23/2008 | CA2372339C Pharmaceutical product comprising the active substance diamorphine, and its use in a process for treating opiate addiction |
| 12/23/2008 | CA2339978C Process for obtaining highly-purified alginates |
| 12/23/2008 | CA2326456C Composition and method of preparing microparticles of water-insoluble substances |
| 12/23/2008 | CA2319810C Propofol composition containing sulfite |
| 12/23/2008 | CA2307040C Multilayer conductive appliance having wound healing and analgesic properties |
| 12/23/2008 | CA2305799C Composition for the treatment of nicotine addiction containing a nicotine receptor antagonist and an anti-depressant or anti-anxiety drug |
| 12/23/2008 | CA2285298C Complexes comprising local anesthetic and nucleic acid and method of making and using the same |
| 12/23/2008 | CA2270318C Coating bituminous substrates |
| 12/23/2008 | CA2263584C Orally applicable formulation of quinolone or naphthyridone carboxylic acids |
| 12/23/2008 | CA2260185C Hormone replacement therapy drug formulations for topical application to the skin |
| 12/23/2008 | CA2246397C Solid and semi-solid hydrocarbon gels and uses thereof |
| 12/23/2008 | CA2187990C Pharmaceutical compositions comprising l-carnitine, or derivative thereof, and trihydroxy or tetrahydroxystilbene |
| 12/23/2008 | CA2178594C Absorption enhancers for topical pharmaceutical formulations |
| 12/23/2008 | CA2175966C Antibacterial oral gel composition for application to dental implant areas |
| 12/23/2008 | CA2100925C Process for preparing microspheres for the prolonged release of the lhrh hormone and its analogues, microspheres and formulations obtained |
| 12/18/2008 | WO2008154645A1 Functional abiotic nanosystems |
| 12/18/2008 | WO2008154500A1 Compositions and methods for polymer-caged liposomes |
| 12/18/2008 | WO2008154339A2 Extended release formulation and method of treating adrenergic dysregulation |
| 12/18/2008 | WO2008154337A1 Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system |
| 12/18/2008 | WO2008154294A1 Method and composition for providing controlled delivery of biologically active substances |
| 12/18/2008 | WO2008154262A1 Stabilized amorphous forms of imatinib mesylate |
| 12/18/2008 | WO2008154234A2 Extended release formulation of nevirapine |
| 12/18/2008 | WO2008153966A1 Mucoadhesive vesicles for drug delivery |
| 12/18/2008 | WO2008153945A2 Nutraceutical co-crystal compositions |
| 12/18/2008 | WO2008153882A1 Benefit agent containing delivery particle |
| 12/18/2008 | WO2008153762A2 S-nitrosothiol formulations and storage systems |
| 12/18/2008 | WO2008153753A2 Compositions and particles containing cellulosic fibers and stabilized- and/or activated- urease inhibitors, as well as methods of making and using the same |
| 12/18/2008 | WO2008153746A1 Formulations and methods for treating dry eye |
| 12/18/2008 | WO2008153582A1 Concentrate esmolol |
| 12/18/2008 | WO2008153035A1 Liposome preparation for iontophoresis comprising insulin enclosed therein |
| 12/18/2008 | WO2008152729A1 Jelly-like pharmaceutical composition containing risperidone |
| 12/18/2008 | WO2008152669A2 Colloidal vectors with polyaminoacid structure for oral release of peptides and proteins and method for their production |
| 12/18/2008 | WO2008152626A2 Uniformly abrasive confectionery product and process therefor |
| 12/18/2008 | WO2008152619A1 Taste masked pharmaceutical compositions of s-alkylisothiouronium derivatives |
| 12/18/2008 | WO2008152598A1 Stabilized pharmaceutical compositions comprising atorvastatin |
| 12/18/2008 | WO2008152401A1 Peptide slow-release formulations |
| 12/18/2008 | WO2008152398A2 Formulations for inhalation |
| 12/18/2008 | WO2008152374A1 Personal lubricant composition |
| 12/18/2008 | WO2008152366A1 Improvements in and relating to mammalian reproduction |
| 12/18/2008 | WO2008152347A2 Pack of medicinal tablets |
| 12/18/2008 | WO2008152262A2 Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system |
| 12/18/2008 | WO2008152106A1 Pharmaceutical formulation comprising an insulin derivative |
| 12/18/2008 | WO2008152052A1 Intradermal influenza vaccine |
| 12/18/2008 | WO2008151811A2 Process for the preparation of a medicament comprising vardenafil hydrochloride trihydrate |
| 12/18/2008 | WO2008151502A1 Enrofloxacin microcapsule formulation and preparation method thereof |
| 12/18/2008 | WO2008151433A1 Injectable polymer-lipid blend for localized drug delivery |
| 12/18/2008 | WO2008129318A3 A foam material for medical use and method for producing same |
| 12/18/2008 | WO2008129270A3 Compositions comprising anti-inflammatory compounds |
| 12/18/2008 | WO2008125778A3 Rehydration composition for preparing a solute by reconstitution in water |
| 12/18/2008 | WO2008120548A3 Oral disintegrating tablet |
| 12/18/2008 | WO2008113992A3 Gel compositions comprising urea derivatives |
| 12/18/2008 | WO2008100930A3 Convection enhanced delivery apparatus, method and application |
| 12/18/2008 | WO2008096237A3 Method for realising active ingredients in order to protect them and optimise their delivery mode |
| 12/18/2008 | WO2008095645A3 Biologically effective device and method for production thereof |
| 12/18/2008 | WO2008088810A3 Formulations for cosmetic and wound care treatments with photosensitizers as fluorescent markers |
| 12/18/2008 | WO2008087491A3 Method for treating or preventing symptoms of hormonal variations |
| 12/18/2008 | WO2008082373A3 Pharmaceutical formulations comprising lipase inhibitor |
| 12/18/2008 | WO2008074461A3 Fluorescent nanoparticles |
| 12/18/2008 | WO2008067164A3 Solid pharmaceutical dosage formulations |
| 12/18/2008 | WO2008053356A3 Immediate release oxymorphone compositions and methods of using same |
| 12/18/2008 | WO2008021847A3 Topical formulation of multilamellar vesicles composition for percutaneous absorption of pharmaceutically active agent |
| 12/18/2008 | WO2008021666A3 Stable liquid levetiracetam compositions and methods |
| 12/18/2008 | WO2007140312A3 Anti-cross-linking agents and methods for inhibiting cross-linking of injectable hydrogel formulations |
| 12/18/2008 | WO2007133525A3 Photodynamic foam composition and sclerosis treatment |
| 12/18/2008 | WO2007087341A3 Tolerogenic biodegradable artificial antigen presenting system |
| 12/18/2008 | WO2007017842A3 Satiety |
| 12/18/2008 | WO2003024455A8 Stent coated with a sustained-release drug delivery and method for use thereof |
| 12/18/2008 | US20080312581 Peptosomes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo |
| 12/18/2008 | US20080312410 Cysteine-containing peptide tag for site-specific conjugation of proteins |
| 12/18/2008 | US20080312407 Glycopeptide phosphonate derivatives |